Literature DB >> 4821458

Autoantibodies and serum immunoglobulin levels in asbestos workers.

A Lange, R Smolik, W Zatoński, J Szymańska.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4821458     DOI: 10.1007/bf02178970

Source DB:  PubMed          Journal:  Int Arch Arbeitsmed        ISSN: 0020-5923


× No keyword cloud information.
  17 in total

1.  RHEUMATOID PNEUMOCONIOSIS IN ASSOCIATION WITH ASBESTOSIS.

Authors:  W K MORGAN
Journal:  Thorax       Date:  1964-09       Impact factor: 9.139

2.  Rheumatoid lung changes associated with asbestosis.

Authors:  A G RICKARDS; G M BARRETT
Journal:  Thorax       Date:  1958-09       Impact factor: 9.139

3.  Immunohistochemical observations on the human silicotic nodule.

Authors:  B Pernis
Journal:  Med Lav       Date:  1963-05       Impact factor: 1.275

4.  Circulating rheumatoid and antinuclear factors in asbestos workers.

Authors:  M Turner-Warwick; W R Parkes
Journal:  Br Med J       Date:  1970-08-29

5.  Serum immunoglobulin levels in workers exposed to benzene, toluene and xylene.

Authors:  A Lange; R Smolik; W Zatoński; J Szymańska
Journal:  Int Arch Arbeitsmed       Date:  1973

6.  Measurements of concentrations of human serum immunoglobulins.

Authors: 
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  Hemolytic activity of asbestos dusts.

Authors:  G C Secchi; A Rezzonico
Journal:  Med Lav       Date:  1968-01       Impact factor: 1.275

8.  Rheumatoid factor in serum of individuals exposed to asbestos.

Authors:  B Pernis; E C Vigliani; I J Selikoff
Journal:  Ann N Y Acad Sci       Date:  1965-12-31       Impact factor: 5.691

9.  Immunoelectrophoretic pattern changes in asbestosis.

Authors:  A Z el-Sewefy; F Hassan
Journal:  Ann Occup Hyg       Date:  1971-03

10.  Rheumatoid pneumoconiosis: a study in colliery populations in the East Midlands coalfield.

Authors:  D C Lindars; D Davies
Journal:  Thorax       Date:  1967-11       Impact factor: 9.139

View more
  18 in total

1.  Immune adherence reactivity of rat alveolar macrophages following inhalation of crocidolite asbestos.

Authors:  K Miller; E Kagan
Journal:  Clin Exp Immunol       Date:  1977-07       Impact factor: 4.330

2.  Immunological studies of patients with asbestosis. I. Studies of cell-mediated immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; E I Beissner; J Gluckman; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

3.  Immunological consequences of asbestos exposure.

Authors:  D P Hartmann
Journal:  Surv Immunol Res       Date:  1985

4.  Immunological studies of patients with asbestosis. II, Studies of circulating lymphoid cell numbers and humoral immunity.

Authors:  E Kagan; A Solomon; J C Cochrane; P Kuba; P H Rocks; I Webster
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

5.  Sequential immunological studies on an asbestos-exposed population. I. Factors affecting peripheral blood leucocytes and T lymphocytes.

Authors:  M M Wagner; M J Campbell; R E Edwards
Journal:  Clin Exp Immunol       Date:  1979-11       Impact factor: 4.330

6.  IgG and IgA enhance the chrysotile-induced production of reactive oxygen metabolites by human polymorphonuclear leucocytes.

Authors:  M Klockars; M Hedenborg; J Koistinen; T Isobe
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

7.  In vitro depression of human lymphocyte mitogen response (phytohaemagglutinin) by asbestos fibres.

Authors:  R G Barbers; W W Shih; A Saxon
Journal:  Clin Exp Immunol       Date:  1982-06       Impact factor: 4.330

8.  Asbestos pleural effusion: a clinical entity.

Authors:  G Mårtensson; S Hagberg; K Pettersson; G Thiringer
Journal:  Thorax       Date:  1987-09       Impact factor: 9.139

9.  Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma.

Authors:  P L Haslam; A Lukoszek; J A Merchant; M Turner-Warwick
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

10.  The histocompatibility antigen in asbestos related disease.

Authors:  N Al Jarad; S Uthayakumar; E J Buckland; T S Green; J Ord; A C Newland; R M Rudd
Journal:  Br J Ind Med       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.